Melobax

Meloxicam, the active ingredient in Melobax, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral formulation for oral use. It is used to relieve pain and inflammation in conditions such as osteoarthritis, rheumatoid arthritis and other musculoskeletal disorders.

GNH USA supplies Melobax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meloxicam belongs to the NSAID class and is indicated for inflammatory joint diseases and related pain conditions. - Osteoarthritis: reduces joint pain and improves functional mobility. - Rheumatoid arthritis: decreases inflammation and slows disease progression. - Musculoskeletal pain: provides analgesia for acute and chronic soft‑tissue discomfort.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Abdominal pain: discomfort in the upper abdomen. - Diarrhea: loose stools occurring intermittently. - Headache: transient cranial pain. - Dizziness: sensation of light‑headedness. - Rash: mild skin redness or itching.

Serious or Rare Side Effects: - Gastrointestinal ulcer or bleeding: potentially life‑threatening hemorrhage. - Cardiovascular thrombotic events: increased risk of heart attack or stroke. - Liver enzyme elevation: signs of hepatic injury. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Renal impairment: reduced kidney function. - Anaphylaxis: acute allergic reaction requiring emergency care.

Before initiating therapy, consider the following safety measures. - Assess gastrointestinal risk: evaluate history of ulcers or bleeding. - Monitor renal function: check creatinine and urine output regularly. - Evaluate cardiovascular status: be cautious in patients with heart disease. - Use lowest effective dose: limit exposure to reduce adverse events. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Store at room temperature: keep in the original pack, protect from moisture.

Meloxicam can affect the activity of several co‑administered medicines.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Lithium: elevated lithium serum levels. - Methotrexate: enhanced toxicity, especially renal.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in renal function. - Diuretics: may potentiate fluid loss and kidney injury. - SSRIs or other antidepressants: modest increase in bleeding tendency.